Terazosin Hydrochloride
- Product NDC
- 69292-202
- 11-digit product format
- 692920202
- Labeler code
- 69292
- Product ID
- 69292-202_0562ff47-168b-44ba-8214-b63f98da2cad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Amici Pharma, Inc.
- Application
- ANDA074823
- Marketing category
- ANDA
- Marketing start
- 2026-05-20
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Terazosin Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERAZOSIN HYDROCHLORIDE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D32S14F082 |
| Rxcui | 260376, 313215, 313217, 313219 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 69292-202-01 | Terazosin Hydrochloride | 100 in 1 BOTTLE | CAPSULE | 100 | | 1 |
| 69292-202-10 | Terazosin Hydrochloride | 1000 in 1 BOTTLE | CAPSULE | 1000 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69292-202-01 | 69292020201 | 100 CAPSULE in 1 BOTTLE (69292-202-01) | 100 capsule | 2026-05-20 | No | No | Historical |
| 69292-202-10 | 69292020210 | 1000 CAPSULE in 1 BOTTLE (69292-202-10) | 1000 capsule | 2026-05-20 | No | No | Historical |